HCP - HCP, Inc.

NYSE - NYSE Delayed Price. Currency in USD
34.95
-0.16 (-0.46%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close35.11
Open35.27
Bid0.00 x 3100
Ask35.73 x 1200
Day's Range34.58 - 35.37
52 Week Range24.47 - 36.07
Volume3,481,687
Avg. Volume2,819,690
Market Cap17.164B
Beta (3Y Monthly)0.13
PE Ratio (TTM)17.10
EPS (TTM)2.04
Earnings DateOct 29, 2019 - Nov 4, 2019
Forward Dividend & Yield1.48 (4.22%)
Ex-Dividend Date2019-08-02
1y Target Est35.12
Trade prices are not sourced from all markets
  • Moody's

    HCP, Inc. -- Moody's assigns P-2 rating to HCP's new commercial paper program and affirms existing ratings

    Moody's Investors Service ("Moody's") has assigned a Prime-2 (P-2) short-term rating to HCP, Inc's $1 billion senior unsecured commercial paper (CP) program in the U.S. Concurrently, Moody's also affirmed all existing ratings of HCP, including its Baa1 senior unsecured debt rating. HCP's P-2 short-term rating reflects the healthcare REIT's strong liquidity position supported by its large unsecured revolving credit facility with a total capacity of $2.5 billion. The CP notes will be issued by HCP, Inc. and rank pari-passu with the REIT's other unsecured senior debt.

  • HCP Announces $1 Billion Commercial Paper Note Program
    PR Newswire

    HCP Announces $1 Billion Commercial Paper Note Program

    IRVINE, Calif., Sept. 18, 2019 /PRNewswire/ -- HCP, Inc. (HCP) announced today that it has established an unsecured commercial paper program (the "Commercial Paper Program"). Under the terms of the Commercial Paper Program, HCP may issue, from time to time, unsecured short-term debt securities with varying maturities not in excess of 397 days from the date of issue (the "Notes").  Amounts available under the Commercial Paper Program may be borrowed, repaid and re-borrowed from time to time, with the maximum aggregate face or principal amount of Notes outstanding at any one time not exceeding $1.0 billion. The proceeds of the Notes will be used for general corporate purposes.  HCP expects to use its revolving credit facility as a liquidity backstop for the repayment of the Notes issued under the Commercial Paper Program.

  • HCP to Buy Life Science Asset, Boost West Cambridge Cluster
    Zacks

    HCP to Buy Life Science Asset, Boost West Cambridge Cluster

    Delivering on its strategy to expand presence in the Boston region, HCP will acquire a trophy life science property -- 35 CambridgePark Drive -- for $332.5 million.

  • HCP to Acquire a Trophy Life Science Property in West Cambridge
    PR Newswire

    HCP to Acquire a Trophy Life Science Property in West Cambridge

    IRVINE, Calif., Sept. 9, 2019 /PRNewswire/ -- HCP, Inc. (HCP) announced today that it executed a definitive agreement to acquire, for $332.5 million, a 224,000 square foot, LEED Gold® laboratory building located at 35 CambridgePark Drive, which is expected to close in December 2019. The property is being purchased from The Davis Companies and Invesco Real Estate ("Invesco").  35 CambridgePark Drive is located in the Cambridge submarket of Boston, Massachusetts, adjacent to HCP's recently acquired property at 87 CambridgePark Drive and future development opportunity at 101 CambridgePark Drive. Combined, HCP has created up to 440,000 square feet of contiguous space across a modern campus.

  • GuruFocus.com

    Hcp Inc (HCP) EVP, CDO and COO Thomas Klaritch Sold $1.3 million of Shares

    EVP, CDO and COO of Hcp Inc (30-Year Financial, Insider Trades) Thomas Klaritch (insider trades) sold 35,014 shares of HCP on 09/04/2019 at an average price of $36.02 a share. Continue reading...

  • Have Insiders Been Selling HCP, Inc. (NYSE:HCP) Shares This Year?
    Simply Wall St.

    Have Insiders Been Selling HCP, Inc. (NYSE:HCP) Shares This Year?

    We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly...

  • Public Storage (PSA) Unveils Storage Units in Murfreesboro
    Zacks

    Public Storage (PSA) Unveils Storage Units in Murfreesboro

    The latest unveiling of Public Storage's (PSA) storage units in Murfreesboro comes as part of the company's effort to expand in this region which has been witnessing rapid growth of the neighborhood.

  • Boston Properties Issues $700M Senior Notes, Refinances Debt
    Zacks

    Boston Properties Issues $700M Senior Notes, Refinances Debt

    Boston Properties (BXP) will redeem its outstanding 5.625% senior notes due in 2020 by using proceed raised from sale of 2.9% senior notes, which will likely result in interest saving.

  • Healthcare REITs: A Boom Is Coming
    Motley Fool

    Healthcare REITs: A Boom Is Coming

    Ventas took a close look at the senior housing market and sees good things ahead for the healthcare real estate investment trust niche.

  • Medical Properties Cheers Investors With 4% Hike in Dividend
    Zacks

    Medical Properties Cheers Investors With 4% Hike in Dividend

    Medical Properties' (MPW) recent quarterly dividend hike indicates the sixth consecutive year of such increase.

  • 4 Reasons Why You Should Add HCP to Your Portfolio Right Now
    Zacks

    4 Reasons Why You Should Add HCP to Your Portfolio Right Now

    HCP's efforts to expand its medical office and life-science portfolio, a diversified and high-quality portfolio and favorable demographic trends make it an attractive pick.

  • Thomson Reuters StreetEvents

    Edited Transcript of HCP earnings conference call or presentation 1-Aug-19 4:00pm GMT

    Q2 2019 HCP Inc Earnings Call

  • HCP Inc (HCP) Q2 2019 Earnings Call Transcript
    Motley Fool

    HCP Inc (HCP) Q2 2019 Earnings Call Transcript

    HCP earnings call for the period ending June 30, 2019.

  • HCP Surpasses Q2 FFO & Revenue Estimates, Raises Outlook
    Zacks

    HCP Surpasses Q2 FFO & Revenue Estimates, Raises Outlook

    HCP witnesses rise in revenues and net operating income in the second quarter of 2019.

  • HCP (HCP) Q2 FFO and Revenues Beat Estimates
    Zacks

    HCP (HCP) Q2 FFO and Revenues Beat Estimates

    HCP (HCP) delivered FFO and revenue surprises of 2.33% and 9.98%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Big Bay Area biotech developer on buying binge as others enter 'funky, oddball niche'
    American City Business Journals

    Big Bay Area biotech developer on buying binge as others enter 'funky, oddball niche'

    This biotech developer is looking to close on at least three properties in the Bay Area this quarter that eventually could add 1 million square feet to its portfolio.

  • HCP Reports Second Quarter 2019 Results
    PR Newswire

    HCP Reports Second Quarter 2019 Results

    IRVINE, Calif. , July 31, 2019 /PRNewswire/ -- HCP, Inc. (NYSE: HCP) today announced results for the second quarter ended June 30, 2019. For the quarter, HCP generated a net loss of $0.03 per share, NAREIT ...

  • Is It Worth Considering HCP, Inc. (NYSE:HCP) For Its Upcoming Dividend?
    Simply Wall St.

    Is It Worth Considering HCP, Inc. (NYSE:HCP) For Its Upcoming Dividend?

    Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

  • Key Factors Setting the Tone for HCP This Earnings Season
    Zacks

    Key Factors Setting the Tone for HCP This Earnings Season

    Focus on life-science and MOB portfolio will likely enable HCP to witness decent growth in Q2. However, prevalent challenges in the senior housing market are a spoilsport.

  • Moody's

    HCP, Inc. -- Moody's announces completion of a periodic review of ratings of HCP, Inc.

    Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of HCP, Inc. New York, July 25, 2019 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of HCP, Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.

  • PR Newswire

    HCP Declares Quarterly Cash Dividend on Common Stock

    IRVINE, Calif. , July 25, 2019 /PRNewswire/ -- HCP, Inc. (NYSE: HCP) announced today that its Board of Directors declared a quarterly common stock cash dividend of $0.37 per share.  The dividend will be ...

  • Could HCP, Inc. (NYSE:HCP) Have The Makings Of Another Dividend Aristocrat?
    Simply Wall St.

    Could HCP, Inc. (NYSE:HCP) Have The Makings Of Another Dividend Aristocrat?

    Is HCP, Inc. (NYSE:HCP) a good dividend stock? How can we tell? Dividend paying companies with growing earnings can be...

  • MarketWatch

    REIT stocks in broad selloff as bond yields rise

    Shares of real estate investment trust are selling off in unanimous fashion, as the better-than-expected June jobs data has fueled in a big jump in Treasury yields. The SPDR Real Estate Select Sector ETF shed 1.0% in midday trading, with all 32 of its equity components losing ground. The REIT ETF (XLRE) tends to act as a bond proxy given its relatively high dividend yield, which means it becomes less attractive to investors when bond prices fall and bond yields rise. The 10-year Treasury yield jumps 10.2 basis points to 2.055% after closing Wednesday at the lowest yield since November 2016. The XLRE's yield is 3.26%, compared with the implied yield for the S&P 500 of 1.93%. Among the XLRE's most-active components, shares of Host Hotels & Resorts Inc. declined 0.8%, Weyerhaeuser Co. lost 1.3%, HCP Inc. dropped 1.5% and Kimco Realty Co. slipped 0.5%. Of the XLRE's highest yielders, shares of Macerich Co. fell 0.4% and yields 9.05%, while Iron Mountain Inc. slid 1.7% and yields 7.78%.

  • GuruFocus.com

    5 Companies Boosting Earnings

    Royal Caribbean, Centene make the list

  • Is CareTrust REIT a Buy?
    Motley Fool

    Is CareTrust REIT a Buy?

    By most metrics, CareTrust looks expensive. But there's a very good reason why investors should consider buying anyway.